MXPA03008762A - Forma de dosificacion oral que contiene nicotina. - Google Patents
Forma de dosificacion oral que contiene nicotina.Info
- Publication number
- MXPA03008762A MXPA03008762A MXPA03008762A MXPA03008762A MXPA03008762A MX PA03008762 A MXPA03008762 A MX PA03008762A MX PA03008762 A MXPA03008762 A MX PA03008762A MX PA03008762 A MXPA03008762 A MX PA03008762A MX PA03008762 A MXPA03008762 A MX PA03008762A
- Authority
- MX
- Mexico
- Prior art keywords
- oral dosage
- nicotine
- dosage form
- containing oral
- directed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27860601P | 2001-03-26 | 2001-03-26 | |
PCT/US2002/008914 WO2002076211A1 (en) | 2001-03-26 | 2002-03-22 | Nicotine-containing oral dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03008762A true MXPA03008762A (es) | 2004-02-18 |
Family
ID=23065632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03008762A MXPA03008762A (es) | 2001-03-26 | 2002-03-22 | Forma de dosificacion oral que contiene nicotina. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1372392A4 (pt) |
JP (1) | JP2004525928A (pt) |
CN (2) | CN101301275A (pt) |
AR (1) | AR033444A1 (pt) |
AU (1) | AU2002252470B2 (pt) |
BR (1) | BR0208382A (pt) |
CA (1) | CA2440713A1 (pt) |
MX (1) | MXPA03008762A (pt) |
NZ (1) | NZ528167A (pt) |
PL (1) | PL364621A1 (pt) |
WO (1) | WO2002076211A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040253307A1 (en) * | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
AR045076A1 (es) * | 2003-07-24 | 2005-10-12 | Smithkline Beecham Plc | Composicion de pelicula que se disuelve oralmente, pelicula multicomponente que se disuelve oralmente, uso de la composicion de pelicula y de la pelicula que se disuelve oralmente para preparar un medicamento, forma de dosificacion oral y procedimiento para preparar la composicion de pelicula que se |
GB0320854D0 (en) | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
EP1691631A4 (en) | 2003-11-07 | 2012-09-05 | Us Smokeless Tobacco Co | TOBACCO COMPOSITIONS |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
WO2006020686A1 (en) * | 2004-08-11 | 2006-02-23 | Cadbury Adams Usa Llc | Warming compositions and delivery systems therefor |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | BIOSYNCHRONE TRANSDERMAL MEDICINES |
US20080131508A1 (en) * | 2006-12-01 | 2008-06-05 | Cephalon, Inc | Oral transmucosal nicotine dosage form |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
GB2448224B (en) | 2007-04-02 | 2010-09-01 | Parkinson S Inst | Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent |
DE102008012015A1 (de) | 2008-03-01 | 2009-09-10 | Südzucker AG Mannheim/Ochsenfurt | Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung |
BR112012020731A2 (pt) * | 2010-02-18 | 2016-04-26 | Jatin Vasant Thakkar | pastilhas gelatinosas suaves com nicotina. |
US20110274628A1 (en) * | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
UA112974C2 (uk) | 2010-09-16 | 2016-11-25 | Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид | Нікотиновмісна композиція (варіанти) |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) * | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9044035B2 (en) * | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
AR096223A1 (es) * | 2013-05-10 | 2015-12-16 | Glaxosmithkline Llc | Pastilla de nicotina para administración oral |
CN104132895B (zh) * | 2014-07-08 | 2017-08-25 | 国家烟草质量监督检验中心 | 适用于连续流动法测定烟草及烟草制品中总植物碱的缓冲体系 |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
SE541358C2 (en) * | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
US20230053622A1 (en) * | 2020-01-15 | 2023-02-23 | Mcneil Ab | Lozenge |
US20220313678A1 (en) * | 2021-04-06 | 2022-10-06 | Altria Client Services Llc | Spray dried nicotine for inclusion in oral products |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310412D0 (en) * | 1993-05-20 | 1993-07-07 | Danbiosyst Uk | Nasal nicotine system |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
DE19536394A1 (de) * | 1995-09-29 | 1997-04-03 | Basf Ag | Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze |
DE19639342C2 (de) * | 1996-09-25 | 1998-07-16 | Suedzucker Ag | Kaugummi, enthaltend ein Süßungsmittel |
US6322806B1 (en) * | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
-
2002
- 2002-03-22 CN CNA2008101253651A patent/CN101301275A/zh active Pending
- 2002-03-22 NZ NZ528167A patent/NZ528167A/en not_active IP Right Cessation
- 2002-03-22 PL PL02364621A patent/PL364621A1/xx not_active Application Discontinuation
- 2002-03-22 AR ARP020101068A patent/AR033444A1/es unknown
- 2002-03-22 BR BR0208382-5A patent/BR0208382A/pt not_active IP Right Cessation
- 2002-03-22 MX MXPA03008762A patent/MXPA03008762A/es active IP Right Grant
- 2002-03-22 CA CA002440713A patent/CA2440713A1/en not_active Abandoned
- 2002-03-22 JP JP2002574739A patent/JP2004525928A/ja active Pending
- 2002-03-22 EP EP02721544A patent/EP1372392A4/en not_active Withdrawn
- 2002-03-22 AU AU2002252470A patent/AU2002252470B2/en not_active Ceased
- 2002-03-22 CN CNA028073339A patent/CN1553771A/zh active Pending
- 2002-03-22 WO PCT/US2002/008914 patent/WO2002076211A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
NZ528167A (en) | 2005-04-29 |
JP2004525928A (ja) | 2004-08-26 |
BR0208382A (pt) | 2004-06-15 |
EP1372392A1 (en) | 2004-01-02 |
EP1372392A4 (en) | 2004-06-23 |
CN101301275A (zh) | 2008-11-12 |
PL364621A1 (en) | 2004-12-13 |
WO2002076211A1 (en) | 2002-10-03 |
CA2440713A1 (en) | 2002-10-03 |
AU2002252470B2 (en) | 2008-05-22 |
CN1553771A (zh) | 2004-12-08 |
AR033444A1 (es) | 2003-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03008762A (es) | Forma de dosificacion oral que contiene nicotina. | |
MXPA05002942A (es) | Forma de dosificacion oral de liberacion modificada. | |
HK1076605A1 (en) | Formulations | |
UA84266C2 (uk) | Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування | |
MXPA04004173A (es) | Formas orales de liberacion controlada utiles para la reduccion o prevencion de la ansiedad hacia la nicotina. | |
NZ548215A (en) | Effervescent oral opiate dosage form | |
MY144659A (en) | 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors | |
HUP0302086A2 (hu) | Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására | |
TW200510375A (en) | New compounds | |
TW200505498A (en) | Sugar-free oral transmucosal solid dosage forms and uses thereof | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
MXPA03010549A (es) | Formas de dosificacion de oxcarbazepina. | |
MXPA03006476A (es) | Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas. | |
NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
MXPA02002249A (es) | Composiciones farmaceuticas agradables al paladar para animales de compania. | |
NZ527867A (en) | Oral pharmaceutical composition of cefpodoxime proxetil | |
TWI264311B (en) | Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency | |
RS50593B (sr) | Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela | |
SE0100569D0 (sv) | New compounds | |
SE0103211D0 (sv) | New formulations and use thereof | |
HUP0104647A2 (hu) | Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény | |
SE0102440D0 (sv) | New compound | |
SI1596841T1 (sl) | Terapevtski sistem amoksicilina in klavulanske kisline | |
PL359727A1 (en) | Crystalline pharmaceutical | |
IL159789A0 (en) | Active ingredient combination for pharmacological therapy of nicotine dependence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |